CJC-1295/Ipamorelin
A combination of CJC-1295 (no DAC) and Ipamorelin, two growth hormone secretagogues. This is the no-DAC form, also known as modified GRF (1-29): it does not carry the DAC (Drug Affinity Complex) modification that extends CJC-1295's half-life to several days, so it is studied for short, pulsatile GH release. Ipamorelin provides selective GH release. Studied together for their synergistic effects on GH release without significant impact on cortisol or prolactin levels. For research use only. Not for human consumption.
$74.99CAD
Select size:
Bundle of 10 — save 20% off
$74.99 $59.99 / unit
SKU: CJCIPAM-10
Need help with dosing? Try our calculatorFor research use only. Not for human consumption.
Frequently Asked Questions
What is CJC-1295 / Ipamorelin?▼
This blend pairs CJC-1295 without DAC, a growth-hormone-releasing hormone (GHRH) analog, with Ipamorelin, a selective ghrelin-receptor agonist. Both are studied in growth-hormone-axis research. Supplied for laboratory research use only — not for human consumption.
Does this blend contain DAC?▼
No. This is the no-DAC form of CJC-1295, also known as modified GRF (1-29). The DAC (Drug Affinity Complex) modification is what extends CJC-1295's half-life to several days; without it, the peptide is short-acting and is studied for pulsatile GH release.
Why are CJC-1295 and Ipamorelin studied together?▼
They act on the GH axis through complementary mechanisms — a GHRH analog and a GH secretagogue — so they are commonly investigated as a pair in secretagogue research.
How is the blend tested and stored?▼
Each peptide is third-party tested by HPLC and mass spectrometry, with a Certificate of Analysis available on request. Stored lyophilized and cold (refrigerated or frozen), then refrigerated after reconstitution, following your lab's protocols.
Is it sold for research use only?▼
Yes. Peptide Depot supplies it in Canada strictly for laboratory and research use — not approved for human or veterinary use, and not intended for consumption.
For shipping, payment, and general questions, see our FAQ.